Skip to main content

Remote Job Finders (RJF)

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B

The deal, which involves a $700 million upfront payment, gives AbbVie access to ISB 2001, a clinical-stage first-in-class trispecific antibody currently being tested for certain kinds of multiple myeloma as well as autoimmune indications.

Gilead to Provide New HIV Drug to Lower-Income Countries Through Novel Philanthropic Partnership

The Global Fund to Fight AIDS, Tuberculosis and Malaria will work with Gilead and other private backers to ensure the HIV preventive Yeztugo, approved last month by the FDA, is available in low- and middle-income countries, concurrent with high-income nations.
Scroll to top